Preview

Архивъ внутренней медицины

Расширенный поиск

Концепция снижения вреда от табака: прошлое, настоящее, будущее

https://doi.org/10.20514/2226-6704-2021-11-6-405-415

Полный текст:

Аннотация

Концепция «снижения вреда от табака» (СВОТ) является темой для дискуссии в контексте международной борьбы против употребления любых видов табака. Такая концепция предполагает предоставление потребляющим табак лицам, которые не могут или не желают прекратить табакокурение или потребление других видов табака (нюхательный, жевательный), менее вредную табачную продукцию с модифицированным риском (ТПМР) для дальнейшего употребления. Скептицизм в отношении СВОТ огромен и связан с негативным опытом табачных компаний по выпуску сигарет с низким содержанием табачных смол/никотина, которые должны были иметь существенно более низкие риски для здоровья чем обычные сигареты. Парадоксально, но именно такой опыт послужил трамплином к росту числа табачных изделий, которые потенциально обладают свойствами ТПМР. Более того, некоторые члены антитабачной коалиции, включая ВОЗ, рассматривают переход табакокурильщиков на ТПМР как стратегию с большим потенциалом. Однако, Европейская группа специалистов считает, что стратегия СВОТ не работает и приведёт к привыканию к табаку ещё одного поколения молодых лиц. В этой статье мы подвергли критическому анализу историю прошлого и настоящего табачных изделий, мифы и противоречия вокруг них. Мы постарались максимально объективно оценить современную концепцию СВОТ, обладающую высоким потенциалом к реальному сокращению числа смертей, связанных с табакокурением.

Об авторах

С. Л. Бабак
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова», Минздрава России
Россия

Москва



М. В. Горбунова
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова», Минздрава России
Россия

Москва



А. Г. Малявин
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова», Минздрава России
Россия

Москва



И. В. Шашенков
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова», Минздрава России
Россия

Москва



Список литературы

1. WHO global report on trends in prevalence of tobacco use 2000–2025. 3rd ed. World Health Organization; Geneva: 2019. License: CC BY-NC-SA 3.0 IGO [Electronic resource]. URL: https://apps.who.int/iris/handle/10665/330221. (Date of the application: 04.07.2021).

2. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014. PMID: 24455788. [Electronic resource]. URL: https://www.ncbi.nlm.nih.gov/books/NBK179276. (Date of the application: 04.07.2021).

3. United States Public Health Service Office of the Surgeon General; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. Smoking Cessation: A Report of the Surgeon General [Internet]. Washington (DC): US Department of Health and Human Services; 2020. PMID: 32255575. [Electronic resource]. URL: https://www.ncbi.nlm.nih.gov/books/NBK555591.(Date of the application: 04.07.2021).

4. Fulmer E, Rogers T, Glasgow L et al. Evaluating Comprehensive State Tobacco Prevention and Control Programs Using an Outcome Indicator Framework. Health Promot Pract. 2019 Mar; 20(2): 214-222.doi: 10.1177/1524839918760557.

5. Institute of Medicine (US) Committee to Assess the Science Base for Tobacco Harm Reduction. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Stratton K, Shetty P, Wallace R, Bondurant S, editors. Washington (DC): National Academies Press (US); 2001. PMID: 25057541. [Electronic resource]. URL: https://www.ncbi.nlm.nih.gov/books/NBK222375. (Date of the application: 04.07.2021).

6. Kozlowski LT. Younger Individuals and Their Human Right to Harm Reduction Information Should Be Considered in Determining Ethically Appropriate Public Health Actions. Nicotine Tob Res. 2020 May 26; 22(6): 1051-1053. doi: 10.1093/ntr/ntz049.

7. Garrett BE, Martell BN, Caraballo RS et al. Socioeconomic Differences in Cigarette Smoking Among Sociodemographic Groups. Prev Chronic Dis. 2019 Jun 13; 16: E74. doi: 10.5888/pcd16.180553.

8. Hwong AR, Schmittdiel J, Schillinger D et al. Smoking cessation treatment for individuals with comorbid diabetes and serious mental illness in an integrated health care delivery system. Addict Behav. 2021 Mar; 114: 106697. doi: 10.1016/j.addbeh.2020.106697.

9. Samet JM. Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Surg Clin. 2013 May; 23(2): 103-12. doi: 10.1016/j.thorsurg.2013.01.009

10. Proctor RN. The history of the discovery of the cigarette-lung cancer link: evidentiary traditions, corporate denial, global toll. Tob Control. 2012 Mar; 21(2): 87-91. doi: 10.1136/tobaccocontrol-2011-050338.

11. Proctor RN. The Cigarette: A Political History-The Past, Present, and Future of US Tobacco. JAMA. 2020 Jul 7; 324(1): 10-11. doi: 10.1001/jama.2020.8237.

12. Atuegwu NC, Perez MF, Oncken C, Thacker S, Mead EL, Mortensen EM. Association between Regular Electronic Nicotine Product Use and Self-reported Periodontal Disease Status: Population Assessment of Tobacco and Health Survey. Int J Environ Res Public Health. 2019 Apr 9; 16(7): 1263. doi: 10.3390/ijerph16071263.

13. Musk AW, de Klerk NH. History of tobacco and health. Respirology. 2003 Sep; 8(3): 286-90. doi: 10.1046/j.1440-1843.2003.00483.x..

14. Creamer MR, Wang TW, Babb S et al. Tobacco Product Use and Cessation Indicators Among Adults — United States, 2018. MMWR Morb Mortal Wkly Rep. 2019 Nov 15; 68(45): 1013-1019. doi: 10.15585/mmwr.mm6845a2.

15. Song MA, Benowitz NL, Berman M et al. Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma. J Natl Cancer Inst. 2017 Dec 1; 109(12): djx075. doi: 10.1093/jnci/djx075.

16. Carroll DM, Stepanov I, O’Connor R et al. Impact of Cigarette Filter Ventilation on U.S. Smokers’ Perceptions and Biomarkers of Exposure and Potential Harm. Cancer Epidemiol Biomarkers Prev. 2021 Jan; 30(1): 38-44. doi: 10.1158/1055-9965.EPI-20-0852.

17. Chido-Amajuoyi OG, Yu RK, Agaku I et al. Exposure to Court-Ordered Tobacco Industry Antismoking Advertisements Among US Adults. JAMA Netw Open. 2019 Jul 3; 2(7): e196935. doi: 10.1001/jamanetworkopen.2019.6935.

18. Food and Drug Administration, HHS. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. Final rule. Fed Regist. 2016 May 10; 81(90): 28973-9106. PMID: 27192730

19. Russell MA. Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br Med J. 1976 Jun 12; 1(6023): 1430-3. doi: 10.1136/bmj.1.6023.1430.

20. Russell MA. The future of nicotine replacement. Br J Addict. 1991 May; 86(5): 653-8. doi: 10.1111/j.1360-0443.1991.tb01825.x. PMID: 1859935.

21. Clarke E, Thompson K, Weaver S et al. Snus: a compelling harm reduction alternative to cigarettes. Harm Reduct J. 2019 Nov 27; 16(1): 62. doi: 10.1186/s12954-019-0335-1.

22. Nelson PR, Chen P, Battista DR, et al. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge. Nicotine Tob Res. 2019 Jan 1; 21(1): 88-94. doi: 10.1093/ntr/nty011.

23. European Commission, 2017. Special Eurobarometer 458; Attitudes of Europeans towards tobacco and electronic cigarettes. European Commission, Directorate-General for Health and Food Safety (DG SANTE). [Electronic resource]. URL: https://ntakd.lrv.lt/uploads/ntakd/documents/files/ebs_458_en.pdf. (Date of the application: 04.07.2021)

24. Farley SM, Sisti J, Jasek J et al. Flavored Tobacco Sales Prohibition (2009) and Noncigarette Tobacco Products in Retail Stores (2017), New York City. Am J Public Health. 2020 May; 110(5): 725-730. doi: 10.2105/AJPH.2019.305561..

25. Hatsukami DK, Carroll DM. Tobacco harm reduction: Past history, current controversies and a proposed approach for the future. Prev Med. 2020 Nov; 140: 106099. doi: 10.1016/j.ypmed.2020.106099.

26. U.S. Food and Drug Administration. Modified Risk Tobacco Products. 2021. [Electronic resource]. URL: http s://www.fda.gov/tobaccoproducts/advertising-and-promotion/modified-risk-tobaccoproducts. (Date of the application: 04.07.2021)

27. Ali FRM, Diaz MC, Vallone D et al. E-cigarette Unit Sales, by Product and Flavor Type — U nited States, 2014-2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 18; 69(37): 1313-1318. doi: 10.15585/mmwr.mm6937e2.

28. FDA Finalizes Enforcement Policy on Unauthorized Flavored Cartridge-based E-cigarettes That Appeal to Children, Including Fruit and Mint. [press release 01/02/2020]. [Electronic resource]. URL: https://www.fda.gov/news-events/press-announcements/fda-finalizes-enforcement-policy-unauthorized-flavored-cartridgebased-e-cigarettes-appeal-children. (Date of the application: 04.07.2021)

29. Pisinger C, Dagli E, Filippidis FT, et al. ERS Tobacco Control Committee, on behalf of the ERS. ERS and tobacco harm reduction. Eur Respir J. 2019 Dec 4;54(6):1902009. doi: 10.1183/13993003.02009-2019.

30. Feliu A, Fernandez E, Martinez C et al. Are smokers “hardening” or rather “softening”? An ecological and multilevel analysis across 28 European Union countries. Eur Respir J. 2019 Sep 19; 54(3): 1900596. doi: 10.1183/13993003.00596-2019.

31. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in realworld and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016 Feb; 4(2): 116-28. doi: 10.1016/S2213-2600(15)00521-4.

32. Sung HY, Wang Y, Yao T et al. Polytobacco Use and Nicotine Dependence Symptoms Among US Adults, 2012-2014. Nicotine Tob Res. 2018 Aug 14;20(suppl_1):S88-S98. doi: 10.1093/ntr/nty050.

33. Sinha DN, Suliankatchi RA, Gup ta PC et al. Global burden of all-cause and cause-specific mortality due to smokeless tobacco use: systematic review and meta-analysis. Tob Control. 2018 Jan; 27(1): 35-42. doi: 10.1136/tobaccocontrol-2016-053302.

34. Adermark L, Galanti MR, Ryk C et al. Prospective association between use of electronic cigarettes and use of conventional cigarettes: a systematic review and meta-analysis. ERJ Open Res. 2021 Jul 12; 7(3): 00976-2020. doi: 10.1183/23120541.00976-2020.

35. Filippidis FT, Laverty AA, Mons U et al. Changes in smoking cessation assistance in the European Union between 2012 and 2017: pharmacotherapy versus counselling versus e-cigarettes. Tob Control. 2019 Jan; 28(1): 95-100. doi: 10.1136/tobaccocontrol-2017-054117.

36. White CM, Pickworth WB, Sved AF et al. Using Product Standards to Render the Most Harmful Tobacco Products Minimally Addictive: Maximum Nicotine Level, Non-Nicotine Constituents, and Scope. Nicotine Tob Res. 2019 Dec 23; 21(Suppl 1):S13-S15. doi: 10.1093/ntr/ntz121.

37. Kaplan BA, Koffarnus MN, Franck CT et al. Effects of Reduced-Nicotine Cigarettes Across Regulatory Environments in the Experimental Tobacco Marketplace: A Randomized Trial. Nicotine Tob Res. 2021 Jun 8; 23(7): 1123-1132. doi: 10.1093/ntr/ntaa226.

38. Ribisl KM, Hatsukami DK, Huang J et al. Strategies to Reduce Illicit Trade of Regular Nicotine Tobacco Products After Introduction of a Low-Nicotine Tobacco Product Standard. Am J Public Health. 2019 Jul; 109(7): 1007-1014. doi: 10.2105/AJPH.2019.305067.

39. Sohlberg T, Wennberg P. Snus cessation patterns — a long-term follow-up of snus users in Sweden. Harm Reduct J. 2020 Sep 10;17(1):62. doi: 10.1186/s12954-020-00405-z.

40. Mallock N, Pieper E, Hutzler C et al. Heated Tobacco Products: A Review of Current Knowledge and Initial Assessments. Front Public Health. 2019 Oct 10; 7: 287. doi: 10.3389/fpubh.2019.00287.

41. Schaller JP, Keller D, Poget L, et al. Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S27-S47. doi: 10.1016/j.yrtph.2016.10.001.

42. Poussin C, Laurent A, Peitsch MC et al. Systems toxicology-based assessment of the candidate modified risk tobacco product THS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells. Toxicology. 2016 Jan 2; 339: 73-86. doi: 10.1016/j.tox.2015.11.007.

43. Ansari SM, Lama N, Blanc N et al. Evaluation of Biological and Functional Changes in Healthy Smokers Switching to the Tobacco Heating System 2.2 Versus Continued Tobacco Smoking: Protocol for a Randomized, Controlled, Multicenter Study. JMIR Res Protoc. 2018 Aug 24;7(8):e11294. doi: 10.2196/11294.

44. Lüdicke F, Ansari SM, Lama N et al. Effects of Switching to a Heat-Not-Burn Tobacco Product on Biologically Relevant Biomarkers to Assess a Candidate Modified Risk Tobacco Product: A Randomized Trial. Cancer Epidemiol Biomarkers Prev. 2019 Nov; 28(11): 1934-1943. doi: 10.1158/1055-9965.EPI-18-0915.

45. Kopa PN, Pawliczak R. IQOS — a heat-not-burn (HnB) tobacco product — chemical composition and possible impact on oxidative stress and inflammatory response. A systematic review. Toxicol Mech Methods. 2020 Feb; 30(2): 81-87. doi: 10.1080/15376516.2019.1669245.

46. Lee PN, Djurdjevic S, Weitkunat R et al. Estimating the population health impact of introducing a reduced-risk tobacco product into Japan. The effect of differing assumptions, and some comparisons with the U.S. Regul Toxicol Pharmacol. 2018 Dec; 100: 92-104. doi: 10.1016/j.yrtph.2018.10.010.

47. Ratajczak A, Jankowski P, Strus P et al. Heat Not Burn Tobacco Product-A New Global Trend: Impact of Heat-Not-Burn Tobacco Products on Public Health, a Systematic Review. Int J Environ Res Public Health. 2020 Jan 8;17(2):409. doi: 10.3390/ijerph17020409.


Рецензия

Для цитирования:


Бабак С.Л., Горбунова М.В., Малявин А.Г., Шашенков И.В. Концепция снижения вреда от табака: прошлое, настоящее, будущее. Архивъ внутренней медицины. 2021;11(6):405-415. https://doi.org/10.20514/2226-6704-2021-11-6-405-415

For citation:


Babak S.L., Gorbunova M.V., Malyavin A.G., Shashenkov I.V. The Concept of Harm Reduction from Tobacco: Past, Present, Future. The Russian Archives of Internal Medicine. 2021;11(6):405-415. https://doi.org/10.20514/2226-6704-2021-11-6-405-415

Просмотров: 367


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2226-6704 (Print)
ISSN 2411-6564 (Online)